vs
NATIONAL HEALTH INVESTORS INC（NHI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
NATIONAL HEALTH INVESTORS INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$105.8M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 23.4%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-57.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.9%）
Oscar Health是美国营利性健康保险公司，2012年由约书亚·库什纳、凯文·纳泽米和马里奥·施洛瑟创立，总部位于纽约市。公司深耕健康保险领域，通过远程医疗、医疗专用技术界面及透明的理赔定价体系，降低患者的服务使用难度。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NHI vs PBYI — 直观对比
营收规模更大
NHI
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出4.3%
23.4%
自由现金流更多
PBYI
多$71.9M
$-57.5M
两年增速更快
PBYI
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.8M | $75.5M |
| 净利润 | $38.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 36.1% | — |
| 营收同比 | 23.4% | 27.7% |
| 净利润同比 | -11.7% | — |
| 每股收益（稀释后） | $0.80 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NHIPBYI
| Q4 25 | $105.8M | $75.5M | ||
| Q3 25 | $89.8M | $54.5M | ||
| Q2 25 | $90.7M | $52.4M | ||
| Q1 25 | $89.3M | $46.0M | ||
| Q4 24 | $85.8M | $59.1M | ||
| Q3 24 | $82.9M | $80.5M | ||
| Q2 24 | $85.0M | $47.1M | ||
| Q1 24 | $81.5M | $43.8M |
净利润NHIPBYI
| Q4 25 | $38.2M | — | ||
| Q3 25 | $32.9M | $8.8M | ||
| Q2 25 | $37.0M | $5.9M | ||
| Q1 25 | $34.2M | $3.0M | ||
| Q4 24 | $43.2M | — | ||
| Q3 24 | $28.5M | $20.3M | ||
| Q2 24 | $35.3M | $-4.5M | ||
| Q1 24 | $30.9M | $-4.8M |
毛利率NHIPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率NHIPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率NHIPBYI
| Q4 25 | 36.1% | — | ||
| Q3 25 | 36.6% | 16.2% | ||
| Q2 25 | 40.8% | 11.2% | ||
| Q1 25 | 38.3% | 6.5% | ||
| Q4 24 | 50.4% | — | ||
| Q3 24 | 34.4% | 25.2% | ||
| Q2 24 | 41.5% | -9.6% | ||
| Q1 24 | 38.0% | -11.0% |
每股收益（稀释后）NHIPBYI
| Q4 25 | $0.80 | $0.26 | ||
| Q3 25 | $0.69 | $0.17 | ||
| Q2 25 | $0.79 | $0.12 | ||
| Q1 25 | $0.74 | $0.06 | ||
| Q4 24 | $0.96 | $0.40 | ||
| Q3 24 | $0.65 | $0.41 | ||
| Q2 24 | $0.81 | $-0.09 | ||
| Q1 24 | $0.71 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.5B | $130.3M |
| 总资产 | $2.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NHIPBYI
| Q4 25 | $19.6M | $97.5M | ||
| Q3 25 | $81.6M | $94.4M | ||
| Q2 25 | $18.6M | $96.0M | ||
| Q1 25 | $135.0M | $93.2M | ||
| Q4 24 | $24.3M | $101.0M | ||
| Q3 24 | $15.6M | $96.7M | ||
| Q2 24 | $14.8M | $96.8M | ||
| Q1 24 | $11.4M | $107.2M |
总债务NHIPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NHIPBYI
| Q4 25 | $1.5B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.5B | $104.7M | ||
| Q1 25 | $1.4B | $97.1M | ||
| Q4 24 | $1.4B | $92.1M | ||
| Q3 24 | $1.2B | $71.1M | ||
| Q2 24 | $1.2B | $48.5M | ||
| Q1 24 | $1.2B | $51.0M |
总资产NHIPBYI
| Q4 25 | $2.8B | $216.3M | ||
| Q3 25 | $2.7B | $202.9M | ||
| Q2 25 | $2.7B | $194.9M | ||
| Q1 25 | $2.8B | $196.2M | ||
| Q4 24 | $2.6B | $213.3M | ||
| Q3 24 | $2.5B | $220.7M | ||
| Q2 24 | $2.5B | $205.0M | ||
| Q1 24 | $2.5B | $214.1M |
负债/权益比NHIPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $236.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-57.5M | $14.4M |
| 自由现金流率自由现金流/营收 | -54.3% | 19.1% |
| 资本支出强度资本支出/营收 | 277.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 6.20× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NHIPBYI
| Q4 25 | $236.6M | $14.4M | ||
| Q3 25 | $62.5M | $9.7M | ||
| Q2 25 | $59.8M | $14.1M | ||
| Q1 25 | $46.5M | $3.6M | ||
| Q4 24 | $207.8M | $15.6M | ||
| Q3 24 | $48.6M | $11.0M | ||
| Q2 24 | $60.7M | $1.0M | ||
| Q1 24 | $40.8M | $11.2M |
自由现金流NHIPBYI
| Q4 25 | $-57.5M | $14.4M | ||
| Q3 25 | $-88.2M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $49.8M | $15.6M | ||
| Q3 24 | $1.5M | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率NHIPBYI
| Q4 25 | -54.3% | 19.1% | ||
| Q3 25 | -98.2% | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 58.1% | 26.4% | ||
| Q3 24 | 1.9% | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度NHIPBYI
| Q4 25 | 277.9% | 0.0% | ||
| Q3 25 | 167.8% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 184.2% | 0.0% | ||
| Q3 24 | 56.8% | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率NHIPBYI
| Q4 25 | 6.20× | — | ||
| Q3 25 | 1.90× | 1.10× | ||
| Q2 25 | 1.62× | 2.41× | ||
| Q1 25 | 1.36× | 1.21× | ||
| Q4 24 | 4.80× | — | ||
| Q3 24 | 1.70× | 0.54× | ||
| Q2 24 | 1.72× | — | ||
| Q1 24 | 1.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
